Meconium Aspiration Syndrome

Watchlist

(log in to enable)

Retrieved

2021-01-23

Source

Orphanet

Trials

—

Genes

ATF2, AGT, AGTR2, NAP1L1, OPTN, NRP1, PTGS2, NOS2, GNAS, LINC01672, CPOX, DMBT1, NANOS2, ACE2, TLR8, TLR7, AMY1A, COX5A, AMY1B, SCGB1A1, TLR4, TLR1, REN, AMY1C, PTGS1, NT5E, NOS3, C5, NOS1, CD14

ATF2, AGT, AGTR2, NAP1L1, OPTN, NRP1, PTGS2, NOS2, GNAS, LINC01672, CPOX, DMBT1, NANOS2, ACE2, TLR8, TLR7, AMY1A, COX5A, AMY1B, SCGB1A1, TLR4, TLR1, REN, AMY1C, PTGS1, NT5E, NOS3, C5, NOS1, CD14, NR3C2, MAS1, KCNJ13, CXCL8, COX8A, GH1, GDNF, AFP

Drugs

Sinapultide, dipalmitoylphosphatidylcholine, palmitoyloleoylphosphatidylglycerol and palmitic acid

Interested in hearing about new therapies?

Meconium aspiration syndrome is a pulmonary complication appearing in newborns with a meconium-stained amniotic fluid. Aspirated meconium can interfere with normal breathing by several mechanisms including airway obstruction, chemical irritation, infection and surfactant inactivation and induces more or less severe signs of respiratory distress at birth.